Polygenic risk scores are being researched for clinical implementation in cancer risk assessment but are not yet routinely used.

“and then there's this other thing that we call polygenic risk poly meaning multiple genetic genes polygenic multiple genes and the number of genes we oftentimes look at in those circumstances may be any anywhere from a hundred to hundreds or even in some cases thousands of genetic variants all mathematically summed together to understand what the risk is associated with that package all of us have genetic variants that go into that polygenic risk and part of the question is along a distribution are you at the high end of that risk curve or are you at the low end or at the average end and So within that this is now something that is not clinically being utilized routinely but we are on a research point of view trying to understand clinical implementation for now those polygenic risks for cancer”